Gaucher+5


 * References**

(1) Biegstraaten, M., Wesnes, K., Luzy, C., Petakov, M., Mrsic, M., Niedereau C., Giraldo, P., Hughes, D., Mehta, A., Mengel, K., Hollak, C., Marodi, L., Schaik, I. (2012). The Cognitive Profile of Type I Gaucher Disease Patients. Retrieved from []. (2) Cleeter, M., Chau, K., Gluck, C., Mehta, A., Hughes, D., Duchen, M., Wood, N., Hardy, J., Cooper, J., Schapira, A. (2010)//. Glucocerebrosidase Inhibition Causes Mitochondrial Dysfunction and Free Radical Damage.// Retrieved from []. (3) Diaz-Font, A., Cormand, B., Blanco, M., Chamoles, N., Chabas, A., Grinberg, D., Vilageliua, L. (2005). //Gene rearrangements in the glucocerebrosidase-metaxin region giving rise to disease-causing mutations and polymorphisms. Analysis of 25 RecNciI alleles in Gaucher disease patients.// Retrieved from []. (4) Enquist, I., Nilsson, E., Ooka, A., Mansson, J.,Olsson, K., Ehinger, M., Brady, R., Richter, J., Karlsson, S. (2009). //Effective Cell and Gene Therapy In a Murine Model of Gaucher Disease.// Retrieved from []. (5) Genetics Home Reference (2012). //GBA gene.// Retrieved from []. (6) MedicineNet (2011). //Definition of Autosomal Recessive.// Retrieved from []. (7) MedicineNet (2011). //Definition of Human Gene Therapy.// Retrieved from [] (8) Pastores, M., Hughes, D. (2011). //Gaucher Disease.// Retrieved from []. (9) Sidransky, E. (2012). //Gaucher Disease: Insights from a Rare Mendelian Disorder.// Retrieved from [].